Logos

Speaker Information

Dr. Michael D. Abramoff, MD, PhD, is an American ophthalmologist, computer scientist and entrepreneur. He is Founder and CEO of IDx, the first company ever to receive FDA clearance for an autonomous AI system. In this capacity, as an expert on AI in healthcare, he has been invited to brief the US Congress, the White House, and the Federal Trade Commission. Dr. Abramoff has published over 250 peer reviewed journal papers (h-index 54) on AI, image analysis, and retinal diseases, and many book chapters. In 2010, Dr. Abramoff’s research findings led him to found IDx to bring to patients more accessible, affordable and higher quality healthcare.

Dr. Natalie Afshari, MD, is the Stuart I. Brown MD Chair in Ophthalmology in Memory of Donald P. Shiley, Chief of Cornea and Refractive Surgery, Vice Chair and Professor of Ophthalmology at the Shiley Eye Institute, University of California, San Diego. Prior to this, she was Professor of Ophthalmology and Director of Centers of Excellence at the Duke University Eye Center. She received her medical degree from Stanford University and her residency and fellowship trainings at Harvard University, Massachusetts Eye and Ear Infirmary.

Dr. Anant Agrawal, PhD, is a Research Electrical Engineer in the Division of Biomedical Physics, part of the Office of Science and Engineering Laboratories at CDRH. He has been with DBP for over 15 years, specializing in optical diagnostic devices and optical radiation safety. He has led a regulatory science program in DBP developing phantom-based test methods for evaluating performance of optical imaging medical devices, which has been funded by a number of intramural research grants from the FDA Critical Path Initiative and Medical Countermeasures Initiative. Anant currently serves on the Ophthalmic Specialty Task Group of the CDRH Standards Program, and he provides premarket reviews of ophthalmic imaging device applications submitted to CDRH. Prior to his time in CDRH, he spent 5 years at a medical device company developing new technology for early cancer detection based on optical imaging and spectroscopy. He has co-authored over 25 peer-reviewed journal articles, 1 book chapter, and 3 US patents. Dr. Agrawal received his Bachelor’s, Master’s and PhD degrees in Electrical Engineering from the University of Virginia, the University of Texas at Austin, and the Catholic University of America, respectively.

Dr. Lama A. Al-Aswad, MD, MPH, an ophthalmologist specialized in glaucoma and cataract surgery, is Associate Professor of Ophthalmology at Columbia University, Glaucoma fellowship director, Chair of quality assurance of the Eye Institute and Director of the Tele-ophthalmology initiative. In 2015, she received her MPH in Health Care policy and Management. She advocates the prevention of blindness as evident from her previous glaucoma screening in NYC, screening >8500 individuals. She recently launched the tele-ophthalmology screening for the 4 leading causes of blindness: glaucoma, cataract, diabetic retinopathy and macular degeneration with an equipped van, real-time data transmission, and central reading.

Dr. Mark S. Blumenkranz, MD, MMS, is HJ Smead Professor Emeritus and Director of the Ophthalmic Innovation Program in the Department of Ophthalmology at Stanford University. He served as the Department Chairman from 1997 until 2015 and played a leading role in the planning, fundraising and construction of the Byers Eye Institute. He is a distinguished vitreo-retinal surgeon and has made notable contributions in the area of new surgical treatments of retinal disease, ophthalmic laser systems, novel pharmaceuticals for macular diseases, ocular gene therapy and ophthalmic digital health and technology development. Dr. Blumenkranz has longstanding interest and expertise in university corporate technology transfer, working with the Stanford Office of Licensing and Technology (OTL).

Dr. Yasmin Bradfield, MD, earned her medical degree at Northwestern University in Chicago, completed an ophthalmology residency at Mayo Clinic in Minnesota, and a pediatric ophthalmology strabismus fellowship at Riley Children’s Hospital in Indianapolis. She has nationally recognized expertise in pediatric glaucoma, and has a busy surgical practice at the University of Wisconsin. Dr. Bradfield has participated in leadership roles for American Association for Pediatric Ophthalmology and Strabismus and Pediatric Eye Disease Investigator Group. She holds the John W. Doolittle Professorship at University of Wisconsin.

Dr. Frank Brodie, MD, MBA, is currently the Innovation Fellow in the Stanford Department of Ophthalmology. He is very active in translational research with a variety of projects and collaborations across a range of topics including pediatric ophthalmology, surgical instrumentation, and intraocular implants. Dr. Brodie founded the Loving Eyes Foundation, a non-profit organization providing custom spectacles for children with craniofacial malformations. He completed his Ophthalmology residency at University of California San Francisco. He completed his MD and MBA at University of Pennsylvania School of Medicine and The Wharton School respectively.

Dr. Joseph Carroll, PhD, is the Richard O. Schultz, MD/Ruth Works Professor of Ophthalmology at the Medical College of Wisconsin. Dr. Carroll and his team utilize a variety of imaging tools to study the structure and function of the living human retina. The group has worked to develop novel image analysis approaches to increase the scientific and clinical utility of these imaging approaches, with over 130 peer-reviewed publications. Patients from around the world travel to the program to participate in a number of studies, which focus on conditions such as albinism, achromatopsia, and retinitis pigmentosa.

Dr. Nicolas Chateau, PhD, cofounded Imagine Eyes in 2003. As the company’s CEO, he has driven the development of ophthalmic imaging devices based on adaptive optics (AO) technology. His team’s work has attracted 7M euro in grant funding and brought several new products to market, including world’s first commercial AO retinal camera. Nicolas has coordinated the deployment of this ultrahigh-resolution imaging device in clinical research centers located in 15 countries. In early 2018, his team initiated the MERLIN project, which is currently developing AO-based retinal imaging devices equipped with multimodal and multiscale functionalities.

Dr. Michael F. Chiang, MD, is Knowles Professor of Ophthalmology and Medical Informatics & Clinical Epidemiology at Oregon Health & Science University (OHSU), and is Associate Director of the OHSU Casey Eye Institute. His clinical practice focuses on pediatric ophthalmology and strabismus. He is board-certified in clinical informatics, and is an elected Fellow of the American College of Medical Informatics. His research has been continuously NIH-funded since 2003, and involves applications of telemedicine, clinical information systems, computer-based image analysis, and genotype-phenotype correlation to improve delivery of health care. His group has published over 150 peer-reviewed journal papers. He directs an NIH-funded T32 training program in visual science for graduate students & postdoctoral fellows at OHSU, directs an NIH-funded K12 mentored clinician-scientist program in ophthalmology, and teaches in both the ophthalmology & biomedical informatics departments.

Dr. Laurence J. Clark, MD, FACP, has been a practicing Internist in Alexandria, VA, from 1980 to the present, and involved in the Medicare Carrier Advisory process since its inception. Dr. Clark is one of the JK Medical Directors and has been licensed as a physician in Virginia since 1980, has served as President of the Medical Staff of the Mount Vernon Hospital in Alexandria, and has been a member of the extended faculty of Georgetown University, his medical alma mater, for seventeen years. After 33 years as a private practitioner, he now devotes his clinical time to the clinic of the Carpenter’s Shelter, a homeless shelter in the City of Alexandria. He continues to educate first and second year medical students in patient evaluation and Ambulatory Care.

Dr. Catherine Cukras, MD, PhD, is a clinical researcher at the National Eye Institute, NIH. Dr. Cukras’ research is focused on the clinical study of human retinal disease (AMD, drug toxicity and monogenetic retina disease), to provide insights into disease pathogenesis, and to develop outcome measures for clinical trials. Her work focuses on correlating anatomic structural measures with the assessment of retina function. Current research studies include longitudinal psychophysical studies of patients with a range of AMD severities, clinical studies of hydroxychloroquine-induced retinal toxicity, late-onset retinal degeneration (LORD) and early phase interventional trials of retinal vein occlusions, X-linked retinoschisis and retinitis pigmentosa.

CDR Brad Cunningham, is the Branch Chief for the Diagnostic and Surgical Devices Branch (DSDB) in the Division of Ophthalmic and ENT Devices at the Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH). During his time at CDRH, he has served as lead and engineering reviewer in the Office of Device Evaluation, and as an regulatory operations officer in the Office of Compliance until 2009 when he was selected as the manager of DSDB. In this role, he directs FDA’s premarket regulatory activities for ophthalmic diagnostic devices, surgical and refractive lasers, software-only diagnostics (including AI-based technology), and retinal implants. During his 16 years at the FDA, he held collateral duty positions, such as the engineering technical expert to ANSI’s Implantable Glaucoma Devices working group and as the interim director for the Division of Patient Safety Partnerships. He has also co-authored several FDA guidance documents and publications. In recent years, he has taken an active leadership role in the development of new policies and regulations around digital health technologies, including devices that incorporate adaptive algorithms and artificial intelligence functionality for automated screening and diagnosis indications. CDR Cunningham received his undergraduate and graduate degrees in bioengineering from the University of Maryland, College Park. He is also a respected officer in the Commissioned Corps of the U.S. Public Health Service, a leader in the Engineering Professional Advisory Committee, the Chair for the Senior Advisory Group for Engineers, and the training coordinator of the PHS-1 Rapid Deployment Force team; a team designed for rapid response to foreign and domestic public health emergencies.

Dr. Alastair Denniston, PhD, MRCP, FRCOphth, leads a Supra-Regional Inflammatory Eye Disease service dedicated to improving the care of patients with uveitis and other sight-threatening inflammatory conditions. He is the author of over 100 peer-reviewed publications, the best-selling Oxford Handbook of Ophthalmology and founder of the international equator vision collaboration. His international research program focuses on quantitative imaging and the development of novel outcome measures to guide treatment decisions in clinic, and to provide the early and late surrogate endpoints to open up the drug development pipeline in uveitis.

Dr. Alfredo Dubra, PhD, has a broad background in optics with training at the National University in Uruguay, Imperial College London and the University of Rochester. His research group is part of the Byers Eye Institute and the Ophthalmology Department at Stanford University. Dr. Dubra’s research seeks to reveal ocular, vascular, neurodegenerative and systemic diseases through the development, translation and dissemination of novel optical ophthalmic imaging technologies.

Dr. Jacque L. Duncan, MD, has over 18 years of experience treating and characterizing patients with inherited retinal degenerations. After graduating from Stanford University, completing her medical degree at the University of California San Francisco (UCSF), and a medical retina fellowship in inherited retinal degenerations at the Scheie Eye Institute at the University of Pennsylvania, Dr. Duncan joined the Ophthalmology Department at UCSF on a K08 Mentored Clinician Scientist Development Award from the National Eye Institute to study novel treatments for inherited retinal degenerations in rodent models. She has worked with Austin Roorda, PhD, and Joe Carroll, PhD, to characterize cone structure and function non-invasively in patients with inherited retinal degenerations using adaptive optics scanning laser ophthalmoscopy (AOSLO). Dr. Duncan works with leading retinal degeneration researchers on the Scientific Advisory Board for the Foundation Fighting Blindness and currently serves as the Scientific Advisory Board Chair.

Dr. Mays El-Dairi, MD, is a Pediatric Neuro-Ophthalmologist with expertise and interest in optic nerve head imaging in pediatric neuro-ophthalmology using spectral domain optical coherence tomography (SDOCT). She serves as a Director of Optic Nerve Grading for adult and pediatric ophthalmology studies. Her expertise is in optic nerve head imaging in pediatric neurologic diseases and glaucoma. She has multiple publications on the use of OCT in pediatric and adult optic nerve edema and optic atrophy.

Dr. Malvina B. Eydelman, MD, For over 20 years, as an Expert Medical Officer, Senior Medical Advisor, Director of the Division of Ophthalmic, Neurological and Ear, Nose and Throat (ENT) Devices and Director of the FDA’s Pilot Office of Ophthalmic, Dental, Respiratory, ENT, Anesthesia and Sleep Devices, Dr. Eydelman has played a key role in assuring the safety and effectiveness of medical devices. Dr. Eydelman guided development of more than 50 international and national standards, oversaw development of numerous regulations and guidance; and convened over 30 public meetings of FDA Medical Device Committees. She originated numerous symposia and workshops to facilitate device innovation and has been instrumental in expediting development of novel endpoints for clinical trials of pioneering technologies. Dr. Eydelman has organized multi-stakeholder public- private partnerships and spearheaded many clinical and laboratory studies designed to improve the safety of medical devices. Dr. Eydelman received her M.D. degree from Harvard Medical School and a Doctorate in Health Sciences and Technology from Massachusetts Institute of Technology (M.I.T.). Dr. Eydelman has been granted a U.S. patent, published nearly 100 peer-reviewed articles, book chapters, and monographs and presented over 200 lectures worldwide.

Rochelle Chodock Fink, MD, JD, is a Senior Health Science Specialist at FDA. In that capacity, she works on joint CMS-FDA efforts to accelerate the regulatory and coverage decision making process. This responsibility includes spending a portion of each week working in CMS’s Coverage and Analysis Group (CAG) and the remainder of the week working at FDA’s Center for Devices and Radiological Health (CDRH). Dr. Fink is involved in the FDA-CMS Parallel Review Program and CDRH’s Pre-Submission Program. As a registered patent attorney, Dr. Fink works on CDRH’s technology transfer and patent matters. Additionally, she establishes collaborations with CDRH and has been involved in the FDA-Medical Device Innovation Consortium (MDIC) effort. Prior to joining CDRH, Dr. Fink worked in CDER’s Office of Regulatory Policy where her primary responsibilities included responding to citizen petitions. Dr. Fink received her undergraduate and medical degrees from Brown University and her law degree from the University of Pennsylvania Law School. She has worked as an associate at Paul, Weiss, Rifkind, Wharton & Garrison, LLP and Sidley Austin, LLP.

Dr. David Glasser, MD, is the Secretary for Federal Affairs for the American Academy of Ophthalmology. He is an assistant professor of ophthalmology at the Johns Hopkins University School of Medicine. Dr. Glasser received his undergraduate degree from Rensselaer Polytechnic Institute and earned his medical degree from Albany Medical College. He completed his residency at Jules Stein Eye Institute (UCLA) and his fellowships in Cornea and External Disease and Corneal Physiology at the Medical College of Wisconsin.

Dr. Daniel X. Hammer, PhD, has over 25 years’ experience in the invention, development, and application of biomedical optics to a broad range of interdisciplinary research programs. His current research interests include optical coherence tomography, adaptive optics, vision science, and neuro-imaging. He is currently the Deputy Director of the Division of Biomedical Physics (FDA/CDRH/OSEL/DBP) at the Food and Drug Administration in Silver Spring MD. He is a member of SPIE (senior member), OSA, ARVO, and AIMBE (fellow).

Dr. Lawrence E. Kagemann PhD, is an adjunct professor of ophthalmology at the NYU Langone Medical Center, NYU School of Medicine, an adjunct professor of ophthalmology at the University of Maryland, and a lead reviewer of ophthalmic devices for the US Food and Drug Administration. Dr. Kagemann is a fellow of the Association for Research in Vision and Ophthalmology with over 130 peer-reviewed publications, and certified in regulatory affairs, serving as a scientific lead for OCT technology at the FDA. His research is focused on functional and structural imaging of the eye, including hemodynamic and metabolic measurements. He has expanded the application of spectral domain and swept-source optical coherence tomography to blood flow and oximetry in the retina, and non-invasive direct measurement of aqueous outflow structures in the living human eye.

Dr. Theodore Leng, MD, MS, trained in ophthalmology at Bascom Palmer Eye Institute and vitreoretinal diseases and surgery at Stanford. As a faculty member at Stanford, he currently serves as Director of Clinical and Translational Research and also conducts research on novel imaging techniques, computer-aided and machine learning analysis of retinal images and cell-based therapies for age-related macular degeneration.

Dr. Cynthia Mattox, MD, recently retired after 25 years of teaching and maintaining a busy referral surgical practice from the Department of Ophthalmology at Tufts University School of Medicine in Boston, Massachusetts, where she was the Director of the Glaucoma and Cataract Service. Dr. Mattox is actively involved with the American Academy of Ophthalmology, currently serving as a Trustee-at-Large, chair of the IRIS Registry Measure Development Task Force, and a member of the IRIS Registry Executive Committee and Analytics Committee, as well as a member of the Academy’s Health Policy Committee since 2004. Dr. Mattox served as the President of the American Glaucoma Society 2017-2018, and has held numerous leadership positions in the AGS.

Felipe A. Medeiros, MD, PhD, is Professor of Ophthalmology and Vice-Chair for Technology at Duke University. He is also Director of the Clinical Research Unit, where he leads clinical research efforts in the Department of Ophthalmology. A large part of Dr. Medeiros’ research has been focused on the use of imaging technologies for diagnosis and detection of glaucoma progression. He has published over 300 peer-reviewed articles and his work has been cited over 15,000 times. He is a previous recipient of the ARVO Cogan Award and is the current Program Chair for the American Glaucoma Society.

Dr. Jessica I. W. Morgan, PhD, earned her PhD in Optics from the University of Rochester in 2008. She is currently an Assistant Professor on the tenure-track in the Scheie Eye Institute, Department of Ophthalmology at the University of Pennsylvania. Dr. Morgan’s laboratory investigates the structure and function of individual photoreceptors in the living human retina noninvasively using high-resolution retinal imaging techniques, with the primary technique being adaptive optics in combination with scanning light ophthalmoscopy (AOSLO).

Dr. David Myung, MD, PhD, is an Assistant Professor of Ophthalmology at the Byers Eye Institute at Stanford (BEIS) and, by courtesy, of Chemical Engineering. He also serves as an attending physician and cataract surgeon at the VA Palo Alto Health Care System. He is Co-Director of the Ophthalmic Innovation Program, a project-based fellowship in the development and regulatory science of new eye care technologies, and is the Director of Teleophthalmology at BEIS. A clinician scientist, Dr. Myung leads an NIH-funded translational research laboratory focused on two areas of clinical need: (1) ophthalmic regenerative medicine through tissue engineering and drug delivery, and (2) telemedicine including remote diabetic screening and global health initiatives through mobile technologies.

Dr. Christopher J. Quinn, OD, currently serves as Immediate Past President of the American Optometric Association (AOA). He received his Doctor of Optometry degree from the Pennsylvania College of Optometry and subsequently participated in a hospital-based residency at the Baltimore VA Hospital, Fort Howard VA Medical Center. He is board certified by the American Board of Optometry, a Fellow of the American Academy of Optometry, Distinguished Practitioner in the National Academies of Practice in Optometry and member of the American Public Health Association Vision Care Section. He has served on the American Medical Association’s Health Care Professionals Advisory Committee to the Specialty Society Relative Value Scale Update Committee (RUC).

Dr. Michael X. Repka, MD, MBA, is professor of ophthalmology and a professor of pediatrics at the Johns Hopkins University School of Medicine. He has been at the Johns Hopkins University School of Medicine since 1983. He received his medical degree from the Jefferson Medical College of Thomas Jefferson University in 1979 and completed his ophthalmology residency at Wills Eye Hospital. He completed his MBA at Johns Hopkins University in 2010. Dr. Repka led the Pediatric Eye Disease Investigator Group funded by the National Eye Institute from 1997 to 2009 as chair and currently serves as past chair for and member of the operations committee. Dr. Repka currently is Vice-chair for Clinical Practice of the Wilmer Institute and Division Director of Pediatric Ophthalmology and Adult Strabismus at the Wilmer Institute of Johns Hopkins University. He also serves as the Medical Director for Governmental Affairs of the American Academy of Ophthalmology. He is a past chair of the FDA’s Ophthalmic and Dermatological Advisory Committee and is currently AAO’s CPT Advisor to the AMA’s CPT Editorial Panel.

Dr. Austin Roorda, PhD, received his PhD from the University of Waterloo in 1996 with joint degrees in Vision Science & Physics. Since then, his academic career (postdoc: University of Rochester (1996-1998); faculty: University of Houston (1998-2004); faculty: UC Berkeley (2005-present)) has focused on the development and use of AO systems for the eye. He is a fellow of OSA, ARVO, and AAO. Notable awards are the Glenn A. Fry Award from the American Academy of Optometry (2009), a John S. Guggenheim Fellowship (2014) and an Alcon Research Institute Award (2016).

Dr. Richard B. Rosen, MD, is a vitreoretinal surgeon and medical retina consultant at the New York Eye and Ear Infirmary, where he serves as Deputy Chair of Clinical Affairs, Vice Chairman of Ophthalmology Research, Surgeon Director and Retina Service Chief. Dr. Rosen is the Pierce Distinguished Chair and Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai and Visiting Professor in Applied Optics at the University of Kent in Canterbury, UK. Dr. Rosen’s research interests include innovations in diagnostic retinal imaging, and vitreoretinal surgical instrumentation, along with new treatments for macular degeneration and diabetic retinopathy.

Dr. SriniVas R. Sadda, MD, is the President and Chief Scientific Officer of the Doheny Eye Institute, the Stephen J. Ryan – Arnold and Mabel Beckman Endowed Chair, and Professor of Ophthalmology at the University of California – Los Angeles (UCLA) Geffen School of Medicine. He received his MD from Johns Hopkins University, where he also completed ophthalmology residency and neuro-ophthalmology and medical retina fellowships (Wilmer Eye Institute). Dr. Sadda’s major research interests include automated retinal image analysis, retinal substructure assessment, and advanced retinal imaging technologies. He has more than 440 peer-reviewed publications and 20 book chapters, and has given over 400 presentations worldwide.

Hilda Scharen, MSc, Capt USPHS, has been serving as the Director, Medical Device Development Tools (MDDT) Program at the FDA’s Center for Devices and Radiological Health (CDRH) for the past year and a half, leading the transition of MDDT from pilot to program in 2017. The MDDT Program aims to reduce regulatory burden and support the innovation of medical devices by qualifying tools which can be relied upon in device evaluation and regulatory decision-making. Prior to her current position, CAPT Scharen has provided leadership, direction, and guidance for a number of Center-wide initiatives, working groups, and issues for 8 years as part of the Center Science Council at CDRH. CAPT Hilda Scharen has a Masters in biomedical engineering and has been at FDA for past 16 years, including serving as a Senior Program Manager at the Center for Drug Evaluation and Research (CDER) for 4 years prior to CDRH. As a senior Commissioned Corps officer in the United States Public Health Service (USPHS), her prior experience includes working at the National Institute of Health (NIH), Office of the Secretary, and Commissioned Corps Operations in the Department of Health and Human Services (HHS).

Dr. Joel S. Schuman, MD, is Professor and Chairman of Ophthalmology and Professor of Neuroscience and Physiology at NYU Langone Medical Center, NYU School of Medicine, and Professor of Biomedical, Electrical & Computer Engineering at NYU Tandon School of Engineering. Dr. Schuman and his colleagues were first to identify a molecular marker for human glaucoma, published in Nature Medicine in 2001. Continuously funded by the National Eye Institute as a principal investigator since 1995, he is an inventor of optical coherence tomography (OCT), used world-wide for ocular diagnostics. Dr. Schuman has published more than 400 peer-reviewed scientific journal articles.

Allison Shuren, MSN, co-chairs the Life Sciences and Healthcare Regulatory practice and advises a wide range of health care clients on regulatory, compliance, enforcement, and legislative matters. Her clients include large international manufacturers of medical devices, pharmaceuticals, biologics, emerging companies with early stage concepts, hospitals and integrated health networks, ambulatory surgery centers, diagnostic testing facilities, clinical laboratories, dialysis centers, physicians, physician practice management companies, and developers of mobile and digital health technology. A primary focus of Ms. Shuren's practice is compliance with health regulatory requirements, especially the healthcare fraud and abuse laws.

Dr. Richard F. Spaide, MD, is a specialist in retinal diseases and has published more than 300 articles in peer-reviewed journals, nearly 50 book chapters, and edited several books. He is in private practice at the Vitreous, Retina, Macula Consultants of New York. His major research interests include macular diseases, retinal surgery, and ocular imaging. Past highlights in his published papers include indocyanine angiography, fundus autofluorescence, characterization of central serous chorioretinopathy, application of mechanical engineering principles to macular hole formation, development of concepts concerning oxidative damage and characterization of lipid peroxides in Bruch's membrane, combination therapy for age-related macular degeneration, and development of new methodologies to image the retina and choroid. His current research interests include multimodal imaging, optical coherence tomography angiography, and new computer-based rendering techniques to visualize retinal anatomy.

Dr. Vivek Srinivasan, PhD, is Associate Professor of Biomedical Engineering and Ophthalmology and Chancellor's Fellow at UC Davis. His group develops new light-based technologies for in vivo imaging and sensing of the brain and eye. Starting with a firm grounding in neurophysiology, vision science, and biomedical engineering, his group employ ideas novel photonic technologies and approaches to accomplish this goal.

Dr. Nadia K Waheed, MD, MPH, is Associate Professor of Ophthalmology and Director of the Imaging Research Fellowship at the Tufts New England Eye Center and the Director of the Boston Image Reading Center. Dr. Waheed received her medical degree summa cum laude from the Aga Khan University Medical School and a Masters in Public Health from the Harvard School of Public Health, followed by a residency in Ophthalmology and fellowships in retina and ocular immunology at the Harvard Medical School Program in Ophthalmology. Dr. Waheed’s research interests include ocular imaging, including optical coherence tomography angiography, diabetic eye disease and age related macular degeneration, as well as clinical trial design and analysis. Her work at the reading center includes developing and validating functional and imaging endpoints for clinical trials. She has published extensively with over 100 peer reviewed publications, and is the co-editor of four books on retinal imaging. She is also a leading expert in the field of advanced retinal imaging and has delivered over 100 invited lectures at various meetings worldwide including several endowed and keynote lectures.

Dr. Mitchell Weikert, MD, is an Associate Professor at the Cullen Eye Institute, Baylor College of Medicine. Prior to pursuing a career in medicine, Dr. Weikert received degrees in electrical and biomedical engineering, and worked as a design engineer in the petroleum industry. He completed both his medical degree and residency at Baylor College of Medicine, where he also served as Chief Resident. He completed his fellowship in cornea, cataract and refractive surgery at the University of Utah’s John A. Moran Eye Center. Dr. Weikert’s research interests include biomedical optics, anterior segment imaging, and intraocular lens calculations.

Dr. Pierre L. Yong, MD, MPH, MS, is a Medical Officer in the Hospital and Ambulatory Policy Group in the Center for Medicare/Centers for Medicare & Medicaid Services (CMS). He works on a variety of issues across physician, inpatient, and outpatient payment systems. Pierre was previously the Director of the Quality Measurement and Value-Based Incentives Group at CMS, where he oversaw Medicare quality reporting and value-based purchasing programs for clinicians, inpatient and outpatient acute and post-acute care settings, and dialysis facilities. Pierre was also the Director of Health Care Quality and Outcomes in the Office of the Assistant Secretary of Planning Evaluation at the U.S. Department of Health and Human Services, where he oversaw projects on value based purchasing, quality, comparative effectiveness research, and patient-centered outcomes research. He received his medical degree from Brown Medical School, his Masters in Public Health from Columbia University, and his Masters in Science in Health Policy Research at the University of Pennsylvania. He completed his Internal Medicine training at New York Presbyterian Hospital, and most recently worked as a hospitalist at the District of Columbia Veterans Affairs Medical Center.